Friend John E. II — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Friend John E. II has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
John E. Friend II is identified in SEC filings dated 2026-07-08 as the Chief Executive Officer of Kazia Therapeutics Ltd. The publicly available SEC context provided here lists only the name, the executive role, and the company affiliation; there are no verified biographical details (birth date, education, career history) available in the provided data. Based on the filing, he is the CEO of the Australian biotechnology company Kazia Therapeutics Ltd as of July 8, 2026. Due to the limited context, no additional biographical facts can be confirmed.
John E. Friend II is identified in SEC filings dated 2026-07-08 as the Chief Executive Officer of Kazia Therapeutics Ltd. The publicly available SEC context provided here lists only the name, the executive role, and the company affiliation; there are no verified biographical details (birth date, education, career history) available in the provided data. Based on the filing, he …
How many SEC Form 4 filings has Friend John E. II submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Friend John E. II's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
